Benzimidazole is the core bicyclic heterocyclic scaffold underlying numerous APIs, including albendazole and omeprazole, making it a foundational synthetic intermediate and structural reference compound across pharmaceutical chemistry. Simson Pharma's Benzimidazole reference standard supports route-of-synthesis impurity identification for benzimidazole-derived drugs.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Benzimidazole Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
